These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18022005)

  • 1. Anti-ox-LDL and anticardiolipin autoantibodies in patients after cardiac transplantation.
    Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M; Szumska-Kostrzewska M
    Transplant Proc; 2007 Nov; 39(9):2870-2. PubMed ID: 18022005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of anti-7-ketocholesterol antibodies in patient sera after heart transplantation.
    Wielkoszyński T; Szewczyk M; Zembala M; Szumska M
    Transplant Proc; 2009 Oct; 41(8):3206-8. PubMed ID: 19857711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease.
    Awadallah SM; Hamad M; Jbarah I; Salem NM; Mubarak MS
    Clin Chim Acta; 2006 Mar; 365(1-2):330-6. PubMed ID: 16274685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
    Becarevic M; Singh S; Majkic-Singh N
    Clin Lab; 2008; 54(3-4):97-101. PubMed ID: 18630740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia.
    Bowen RS; Moodley J; Dutton MF; Fickl H
    J Obstet Gynaecol; 2002 Mar; 22(2):123-6. PubMed ID: 12521691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against oxidized LDL and serum total antioxidant status in active cyclists and ex-cyclists.
    García-Unzueta MT; Gutiérrez-Sánchez JB; de Mier I; Amado JA; Berrazueta JR
    Horm Metab Res; 2003 Sep; 35(9):541-5. PubMed ID: 14517771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
    Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein.
    Mizutani H; Kurata Y; Kosugi S; Shiraga M; Kashiwagi H; Tomiyama Y; Kanakura Y; Good RA; Matsuzawa Y
    Arthritis Rheum; 1995 Oct; 38(10):1382-8. PubMed ID: 7575688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins.
    Wildburger R; Borović S; Zarković N; Tatzber F
    Wien Klin Wochenschr; 2000 Sep; 112(18):798-803. PubMed ID: 11072668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V; Bison E; Ruffatti A; Iliceto S
    Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
    Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
    Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial, phospholipid and oxidized LDL antibodies in patients with endogenous hypercortisolism].
    Malícková K; Jezková J; Janatková I; Fucíková T; Marek J; Pecen L
    Epidemiol Mikrobiol Imunol; 2003 Apr; 52(2):59-65. PubMed ID: 12822535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM; Cojocaru M; Burcin C
    Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
    Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.